Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 6
2004 3
2005 8
2006 3
2007 6
2008 3
2009 7
2010 4
2011 9
2012 8
2013 5
2014 3
2015 5
2016 6
2017 16
2018 12
2019 11
2020 7
2021 8
2022 9
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Results by year

Filters applied: . Clear all
Page 1
Association between concomitant proton pump inhibitor use and survival of patients with metastatic prostate cancer receiving abiraterone acetate: a post-hoc analysis of pooled data from three randomized controlled trials.
Fukuokaya W, Mori K, Yanagisawa T, Akazawa K, Shimomura T, Kimura T. Fukuokaya W, et al. Among authors: akazawa k. Prostate Cancer Prostatic Dis. 2023 Jul 18. doi: 10.1038/s41391-023-00695-x. Online ahead of print. Prostate Cancer Prostatic Dis. 2023. PMID: 37464102
ASO Author Reflections: Long Term Outcomes of Breast Cancer Patients with Local Recurrence After Mastectomy Undergoing Immediate Breast Reconstruction.
Ogiya A, Nagura N, Shimo A, Nogi H, Narui K, Seki H, Mori H, Sasada S, Ishitobi M, Kondo N, Yamauchi C, Akazawa K, Shien T. Ogiya A, et al. Among authors: akazawa k. Ann Surg Oncol. 2023 Oct;30(11):6541-6542. doi: 10.1245/s10434-023-13925-2. Epub 2023 Jul 15. Ann Surg Oncol. 2023. PMID: 37454021 No abstract available.
Long-Term Outcomes of Breast Cancer Patients with Local Recurrence After Mastectomy Undergoing Immediate Breast Reconstruction: A Retrospective Multi-institutional Study of 4153 Cases.
Ogiya A, Nagura N, Shimo A, Nogi H, Narui K, Seki H, Mori H, Sasada S, Ishitobi M, Kondo N, Yamauchi C, Akazawa K, Shien T; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Ogiya A, et al. Among authors: akazawa k. Ann Surg Oncol. 2023 Oct;30(11):6532-6540. doi: 10.1245/s10434-023-13832-6. Epub 2023 Jul 5. Ann Surg Oncol. 2023. PMID: 37405666
Reduced-dose WBRT combined with SRS for 1-4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control.
Nakano T, Aoyama H, Onodera S, Igaki H, Matsumoto Y, Kanemoto A, Shimamoto S, Matsuo M, Tanaka H, Oya N, Matsuyama T, Ohta A, Maruyama K, Tanaka T, Kitamura N, Akazawa K, Maebayashi K; Japanese Radiation Oncology Study Group 13-1 (JROSG13-1) Investigators. Nakano T, et al. Among authors: akazawa k. Clin Transl Radiat Oncol. 2022 Sep 27;37:116-129. doi: 10.1016/j.ctro.2022.09.005. eCollection 2022 Nov. Clin Transl Radiat Oncol. 2022. PMID: 36199814 Free PMC article.
A Randomized Controlled Phase 2 Study of Neoadjuvant Eribulin Versus Paclitaxel in Women with Operable Breast Cancer: The JONIE-3 Study.
Narui K, Miura D, Hasegawa Y, Tachibana A, Horiguchi J, Hayashi M, Miyashita M, Kubota T, Suzuki M, Yamada K, Yamada A, Akazawa K, Kohno N, Ishikawa T. Narui K, et al. Among authors: akazawa k. Clin Breast Cancer. 2022 Dec;22(8):e881-e891. doi: 10.1016/j.clbc.2022.08.007. Epub 2022 Aug 22. Clin Breast Cancer. 2022. PMID: 36151017 Clinical Trial.
Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma.
Kawakita D, Nagao T, Takahashi H, Kano S, Honma Y, Hirai H, Saigusa N, Akazawa K, Tani K, Ojiri H, Tsukahara K, Ozawa H, Okami K, Kondo T, Togashi T, Fushimi C, Shimura T, Shimizu A, Okamoto I, Okada T, Imanishi Y, Watanabe Y, Otsuka K, Sakai A, Ebisumoto K, Sato Y, Yamazaki K, Ueki Y, Hanazawa T, Saito Y, Ando M, Matsuki T, Nakaguro M, Sato Y, Urano M, Utsumi Y, Kohsaka S, Saotome T, Tada Y. Kawakita D, et al. Among authors: akazawa k. Ther Adv Med Oncol. 2022 Sep 6;14:17588359221119538. doi: 10.1177/17588359221119538. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36090801 Free PMC article.
Predictors and outcomes of ischemia-driven target lesion revascularization in deferred lesion based on fractional flow reserve: a multi-center retrospective cohort study.
Sato T, Goto S, Kishi S, Yamaguchi K, Warisawa T, Kozuki A, Toshihiro S, Tsuchida K, Yokoi H, Kazuya K, Akazawa K, Aizawa Y. Sato T, et al. Among authors: akazawa k. Cardiovasc Diagn Ther. 2022 Aug;12(4):485-494. doi: 10.21037/cdt-21-773. Cardiovasc Diagn Ther. 2022. PMID: 36033217 Free PMC article.
132 results